Biomimetic matrix mediated room temperature synthesis and characterization of nano-hydroxyapatite towards targeted drug delivery

RSC Advances ◽  
2016 ◽  
Vol 6 (67) ◽  
pp. 62556-62571 ◽  
Author(s):  
Lubna Sheikh ◽  
Sucheta Tripathy ◽  
Suprabha Nayar

Nucleation and growth of hydroxyapatite nanoparticles in the presence of different matrices acting as a potent drug delivery vehicle.

2018 ◽  
Vol 6 (18) ◽  
pp. 2758-2768 ◽  
Author(s):  
Hongzhao Qi ◽  
Lijun Yang ◽  
Xueping Li ◽  
Qi Zhan ◽  
Donglin Han ◽  
...  

A new exosome-related drug delivery vehicle was explored based on the “STOP” criteria, dramatically promoting the clinical translation of exosomes.


2020 ◽  
Vol 27 ◽  
pp. 102196
Author(s):  
Xiuying Yang ◽  
Dongliang Zhai ◽  
Jia Song ◽  
Rui Qing ◽  
Bochu Wang ◽  
...  

2020 ◽  
Vol 1 (3) ◽  
pp. 469-480
Author(s):  
Ramesh Marasini ◽  
Tuyen Duong Thanh Nguyen ◽  
Sagar Rayamajhi ◽  
Santosh Aryal

A simple and versatile nanoformulation strategy is presented by combining the synthetic lipids, biocompatible polymer, and tumor penetrating peptide (LyP-1) into a composite nanosystem for targeted drug delivery and imaging in a single session. 


2016 ◽  
Vol 45 (3) ◽  
pp. 414-425 ◽  
Author(s):  
Avleen Kaur ◽  
Keerti Jain ◽  
Neelesh Kumar Mehra ◽  
N. K. Jain

2014 ◽  
Vol 2 (36) ◽  
pp. 6089-6096 ◽  
Author(s):  
Dalong Li ◽  
Jinmei He ◽  
Weilu Cheng ◽  
Yadong Wu ◽  
Zhen Hu ◽  
...  

Schematic illustration of a redox-responsive system based on collagen-capped MHAp for cell-targeted drug delivery.


2019 ◽  
Vol 7 (32) ◽  
pp. 4927-4932 ◽  
Author(s):  
Shuang Fu ◽  
Fei Li ◽  
Mingsong Zang ◽  
Zherui Zhang ◽  
Yuancheng Ji ◽  
...  

A new highly efficient targeting drug delivery vehicle based on diselenium-containing ultrathin polymer nanocapsules was designed and prepared.


2021 ◽  
Vol 11 (1) ◽  
pp. 16-27
Author(s):  
Vinoth-Kumar Lakshmanan ◽  
Byoungkwon Kim ◽  
Shreesh Ojha ◽  
Ahmed M. Al-Abd ◽  
Myung Geun Shin ◽  
...  

Nanogels represent an emerging class of drug delivery systems with enhanced renal clearance and serum half-life. However, synthetic polymeric nanogels are immunogenic and less biodegradable than other systems. Protein nanogels, being non-immunogenic; biodegradable; biocompatible; and mechanically, spatially, and temporally tunable, are gaining widespread attention. Elastin, a natural structural component of connective tissue, has enhanced vascular mobility and is highly biodegradable, biocompatible, temperature and pH sensitive, inert in the bloodstream, able to self-assemble, and able to permeate the blood-brain-barrier. In this study, the development of an Elastin Nanogel (ENG) and its functional capacity as a next generation injectable nano-drug carrier was studied. ENG was prepared via an inverse mini-emulsion technique and was characterized and found to be stable at room temperature and cytocompatible with five different prostate cancer cell lines of varied etiologies. Rhodamine-loaded ENG showed enhanced cellular uptake. Blood smear, hemolysis, CBC, PT/APTT, and C3a complement activation assays showed that ENG is vascular tissue compatible and hence meets the objectives of injectable nanogels. The formulated ENG can be efficiently used as an injectable nano-drug carrier for cancer therapy. Moreover, ENG has the potential to encapsulate hydrophobic drugs for targeted drug delivery.


Sign in / Sign up

Export Citation Format

Share Document